ストックスクリーナーアプリを入手
44.24
2.28%
-1.03
アフターアワーズ：
44.36
0.12
+0.27%
前日終値:
$45.27
開ける：
$45
24時間の取引高:
2.62M
Relative Volume:
0.50
時価総額：
$11.67B
収益：
$12.98B
当期純損益:
$1.00B
株価収益率:
11.13
EPS:
3.9757
ネットキャッシュフロー:
$287.00M
1週間 パフォーマンス:
+0.59%
1か月 パフォーマンス:
-15.41%
6か月 パフォーマンス:
-28.89%
1年 パフォーマンス:
+38.86%
1日の値動き範囲:
$44.16
$45.19
1週間の範囲:
$42.74
$47.03
52週間の値動き範囲:
$28.11
$84.38
Agilent Technologies Inc Stock (AA) Company Profile
名前
Agilent Technologies Inc
セクター
電話
412-315-2900
住所
201 ISABELLA STREET, PITTSBURGH, PA
Compare AA vs TMO, DHR, IDXX, A, NTRA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AA
Agilent Technologies Inc
|
44.24 | 11.67B | 12.98B | 1.00B | 287.00M | 3.9757 |
TMO
Thermo Fisher Scientific Inc
|
568.26 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
191.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
544.32 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
138.57 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.99 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (AA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-09 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2026-03-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2026-01-27 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2026-01-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2026-01-08 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-10-08 | 開始されました | Wells Fargo | Overweight |
| 2025-07-08 | 再開されました | Citigroup | Buy |
| 2025-05-15 | ダウングレード | UBS | Buy → Neutral |
| 2025-04-08 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-10-23 | アップグレード | Argus | Hold → Buy |
| 2024-10-17 | アップグレード | B. Riley Securities | Neutral → Buy |
| 2024-10-01 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-09-25 | 再開されました | JP Morgan | Neutral |
| 2024-09-04 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2024-08-12 | アップグレード | UBS | Sell → Buy |
| 2024-08-02 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2024-06-21 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-04-22 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-01-16 | 開始されました | UBS | Sell |
| 2023-12-07 | 開始されました | HSBC Securities | Hold |
| 2023-10-23 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-07-24 | ダウングレード | Argus | Buy → Hold |
| 2023-07-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2023-07-11 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2023-06-22 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-05-11 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-05-08 | 開始されました | JP Morgan | Overweight |
| 2023-02-22 | アップグレード | Citigroup | Neutral → Buy |
| 2023-01-19 | 繰り返されました | B. Riley Securities | Neutral |
| 2022-12-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-07 | 開始されました | UBS | Neutral |
| 2022-09-22 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2022-09-16 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-21 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-04-08 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-03-24 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-11 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-11-17 | 開始されました | Wolfe Research | Outperform |
| 2021-11-02 | アップグレード | Jefferies | Hold → Buy |
| 2021-10-05 | 繰り返されました | JP Morgan | Overweight |
| 2021-09-29 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-09-15 | アップグレード | Argus | Hold → Buy |
| 2021-07-16 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-23 | 再開されました | JP Morgan | Overweight |
| 2021-03-24 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-03-17 | アップグレード | Deutsche Bank | Hold → Buy |
| 2021-03-03 | アップグレード | Goldman | Sell → Buy |
| 2020-09-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-06-16 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2020-03-24 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2020-03-04 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2020-01-17 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-12-17 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-13 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-11-12 | 繰り返されました | B. Riley FBR | Buy |
| 2019-11-07 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-10-21 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2019-09-26 | 繰り返されました | B. Riley FBR | Buy |
| 2019-09-23 | ダウングレード | Goldman | Buy → Neutral |
| 2019-09-11 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-08-16 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-07-19 | ダウングレード | Argus | Buy → Hold |
| 2019-07-11 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-07-09 | ダウングレード | Macquarie | Outperform → Neutral |
| 2019-04-22 | アップグレード | Gabelli & Co | Hold → Buy |
| 2019-04-03 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-04-02 | ダウングレード | Credit Suisse | Outperform → Neutral |
すべてを表示
Agilent Technologies Inc (AA) 最新ニュース
Agilent Technologies stock steadies as investors weigh recent earnings and life-science demand trend - AD HOC NEWS
Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics? - Yahoo Finance UK
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test - Yahoo Finance
Agilent Technologies Inc (A) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Agilent Technologies Inc (A) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Agilent Technologies Inc (A) Institutional Confidence - TradingKey
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
What to Expect From Agilent Technologies' Q3 2026 Earnings Report - inkl
A|Agilent Technologies Inc|Price:139.760|Chg%:+6.300 - TradingKey
Agilent Technologies Inc|Price:138.570|Chg%:-1.185 - TradingKey
Agilent declares Q2 2026 distribution of R$ 0.44 per unit, payable July 28 - Bitget
A Look at Agilent Technologies Inc (A) After 4.7% Gain -- GF Val - GuruFocus
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies (A) Secures EU Certification for Key Diagno - GuruFocus
Why Agilent Technologies Shares Are Rising Today - Quiver Quantitative
Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers - Moomoo
Agilent stock rises on EU approval for cancer diagnostic By Investing.com - Investing.com Australia
Agilent stock rises on EU approval for cancer diagnostic - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test By Investing.com - Investing.com South Africa
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Yahoo Finance
A|Agilent Technologies Inc|Price:138.965|Chg%:-0.775 - TradingKey
Agilent BDR program executes 5-for-1 stock split on ratio adjustment - Bitget
A4881169 Bond Profile — Key Metrics - TradingView
Agilent Technologies (A) Stock Forecast & Analyst Ratings - Moomoo
Agilent stock holds near report levels as earnings metrics stay in view - Ad-hoc-news.de
Agilent Technologies (NYSE:A) Gains Fresh FDA Momentum - Kalkine Media
Agilent Technologies stock trades steady as life sciences demand supports revenue outlook - Ad-hoc-news.de
[Latest] Global Metal Stamping Market Size/Share Worth USD 412.6 Billion by 2035 at a 4.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Michael Buckner Joins Agilent Technologies as Chief Legal Officer - Medical Product Outsourcing
Agilent Technologies stock trades steadily as investors weigh recent earnings and life sciences dema - Ad-hoc-news.de
Agilent increases HALO X-ray Technologies stake - Airports International
HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited - marketscreener.com
Agilent Technologies (A) Stock Analysis: Unlocking a 21% Upside Potential with Robust Market Presence - DirectorsTalk Interviews
Agilent Technologies (A) Wells Fargo 20th Annual Healthcare Conference 2025 Summary - Quartr
Agilent Increases Its Investment in HALO X-ray Technologies - Morningstar
Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now? - Sahm
Agilent Technologies (A) Q2 2025 earnings summary - Quartr
Agilent Technologies (A) Q1 2026 earnings summary - Quartr
Agilent Technologies stock trades steady as recent earnings and life-science demand underpin valuati - Ad-hoc-news.de
Agilent Technologies (A) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
Agilent Technologies (A) Proxy Filing Summary - Quartr
Agilent Technologies (A) Q4 2025 earnings summary - Quartr
Agilent Technologies stock holds support as results stay in focus - Ad-hoc-news.de
Agilent 1260 Infinity II LC by Agilent Technologies Inc.mid-range workhorse for routine labs - Ad-hoc-news.de
Agilent Technologies Inc (A) Stock Down 3.4% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch
Agilent Technologies stock extends focus on earnings and valuation - ad-hoc-news.de
AG8A Bond Profile — Key Metrics - TradingView
A4404722 Bond Profile — Key Metrics - TradingView
World Syringes for AgilentMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Agilent Technologies Inc (AA) 財務データ
収益
当期純利益
現金流量
EPS
0.02%
0.35%
大文字化:
|
ボリューム (24 時間):